CRISM Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
CRISM Therapeutics has a total shareholder equity of $4.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.8M and $662.0K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.38m |
| Equity | US$4.12m |
| Total liabilities | US$662.00k |
| Total assets | US$4.79m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: CRTX's short term assets ($4.8M) exceed its short term liabilities ($662.0K).
Long Term Liabilities: CRTX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CRTX is debt free.
Reducing Debt: CRTX has no debt compared to 5 years ago when its debt to equity ratio was 7%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CRTX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CRTX has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 12% each year.